A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001
Phase 1/2
53
about 4.9 years
18–70
10 sites in CA, FL, KS +5
What this study is about
This trial is testing a treatment called IOV-4001 in adults with melanoma or advanced non-small cell lung cancer. The goal is to see if this treatment is effective and safe.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive IOV-4001
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Phase 2: Objective Response Rate (ORR)
Secondary: CR Rate, Disease Control Rate (DCR), Duration of Response (DOR), Overall Survival (OS), Progression-free Survival (PFS), Safety and Tolerability of IOV-4001
Oncology